Terms: = Brain cancer AND CSF3R, CD114, 1441, ENSG00000119535, GCSFR AND Prognosis
5 results:
1. Gene Expression of
Bark SA; Dalmolin M; Malafaia O; Roesler R; Fernandes MAC; Isolan GR
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474265
[TBL] [Abstract] [Full Text] [Related]
2. Integrated transcriptome, proteome and single-cell sequencing uncover the prognostic and immunological features of colony-stimulating factor 3 receptor in pan-cancer.
Song L; Jiang F; Tian Y; Cao X; Zhu M; Zhang J; Wang X; Deng L
J Gene Med; 2023 Oct; 25(10):e3508. PubMed ID: 36998239
[TBL] [Abstract] [Full Text] [Related]
3. Identification of cd114 Membrane Receptors as a Molecular Target in Medulloblastomas.
Monteiro JM; Reis Ramos JI; Teixeira E Sousa I; Bighetti-Trevisan RL; Ribas Filho JM; Isolan GR
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982406
[TBL] [Abstract] [Full Text] [Related]
4. Overview and recent advances in the targeting of medulloblastoma cancer stem cells.
Paul MR; Zage PE
Expert Rev Anticancer Ther; 2021 Sep; 21(9):957-974. PubMed ID: 34047251
[No Abstract] [Full Text] [Related]
5. Shared molecular targets in pediatric gliomas and ependymomas.
Tsuruta T; Aihara Y; Kanno H; Funase M; Murayama T; Osawa M; Fujii H; Kubo O; Okada Y
Pediatr Blood Cancer; 2011 Dec; 57(7):1117-23. PubMed ID: 21298772
[TBL] [Abstract] [Full Text] [Related]
